The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 9,574 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
ACCURAY INC | COM | 004397105 | 10,396 | 2,300,000 | SH | SOLE | 2,300,000 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 9,823 | 147,000 | SH | SOLE | 147,000 | 0 | 0 | ||
CARDINAL HEALTH INC | COM | 14149Y108 | 9,705 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
CIGNA CORP NEW | COM | 125523100 | 9,720 | 41,000 | SH | SOLE | 41,000 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 19,562 | 1,520,000 | SH | SOLE | 1,520,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 9,944 | 52,000 | SH | SOLE | 52,000 | 0 | 0 | ||
SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 16,319 | 530,000 | SH | SOLE | 530,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 10,485 | 52,000 | SH | SOLE | 52,000 | 0 | 0 |